Search Results

Severe neuroglycopaenia secondary to severe hypoglycaemia from serendipitous overdose of gliclazide without adrenergic or autonomic response

Authors: Ling, G. R.; Singh, K.; Wong, S. Y.; Toh, V. K. L.

Source: Diabetic Medicine, Volume 26, Number 11, November 2009 , pp. 1182-1183(2)

Publisher: Blackwell Publishing

Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas

Authors: Ragia, Georgia; Petridis, Ioannis; Tavridou, Anna; Christakidis, Dimitrios; Manolopoulos, Vangelis G

Source: Pharmacogenomics, Volume 10, Number 11, November 2009 , pp. 1781-1787(7)

Publisher: Future Medicine

All-cause death significantly higher with glibenclamide vs gliclazide

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 2-2(1)

Publisher: Adis International

Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan

Authors: Devendra, D.; Gohel, B.; Bravis, V.; Hui, E.; Salih, S.; Mehar, S.; Hassanein, M.

Source: International Journal of Clinical Practice, Volume 63, Number 10, October 2009 , pp. 1446-1450(5)

Publisher: Blackwell Publishing

Influence of Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Sulfonylurea Drugs

Authors: Xu, Hongmei; Murray, Michael; McLachlan, Andrew J.

Source: Current Drug Metabolism, Volume 10, Number 6, July 2009 , pp. 643-658(16)

Publisher: Bentham Science Publishers

Gliclazide: Severe hypoglycaemia following medication error in an elderly patient: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 16-16(1)

Publisher: Adis International

Interactions Between Herbal Medicines and Prescribed Drugs: An Updated Systematic Review

Authors: Izzo, Angelo A.; Ernst, Edzard

Source: Drugs, Volume 69, Number 13, 10 September 2009 , pp. 1777-1798(22)

Publisher: Adis International

Co-solvent solubilization of some poorly-soluble antidiabetic drugs

Authors: Seedher, Neelam; Kanojia, Mamta

Source: Pharmaceutical Development and Technology, Volume 14, Number 2, April 2009 , pp. 185-192(8)

Publisher: Informa Healthcare

Free fatty acid kinetics during long-term treatment with pioglitazone added to sulfonylurea or metformin in Type 2 diabetes

Authors: Roden, M.; Mariz, S.; Brazzale, A. R.; Pacini, G.

Source: Journal of Internal Medicine, Volume 265, Number 4, April 2009 , pp. 476-487(12)

Publisher: Blackwell Publishing

Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial

Authors: Joshi, Rohina; Galan, BE de; Chalmers, John; Perkovic, Vlado; Patel, Anushka

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 2, March 2009 , pp. 111-118(8)

Publisher: Expert Reviews

Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design

Authors: Vijayalakshmi, P.; Devi, V. Kusum; Narendra, C.; Srinagesh, S.

Source: Drug Development and Industrial Pharmacy, Volume 34, Number 1, January 2008 , pp. 33-45(13)

Publisher: Informa Healthcare

Improved synthesis of 1-[hexahydrocyclopenta[c]pyrrol-2(1H)-yl]3-(4-methylbenzenesulfonyl)urea

Authors: Qian, Chao; Liu, Yan; Chen, Xinzhi

Source: Journal of Chemical Research, Volume 2008, Number 11, November 2008 , pp. 635-636(2)

Publisher: Science Reviews 2000 Ltd

In Vitro and In Vivo Evaluation of a Novel Push-Pull Osmotic Pump with Orifices on Both Side Surfaces

Authors: Li, Wei; Du, Gani; Yang, Xinggang; Zhang, Zhihong; Nie, Shufang; Peng, Bo; Pan, Weisan

Source: Drug Development and Industrial Pharmacy, Volume 34, Number 12, December 2008 , pp. 1350-1355(6)

Publisher: Informa Healthcare

The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)

Authors: Barnett; Krentz; Strojek; Sieradzki; Azizi; Embong; Imamoglu; Perušičová; Uličiansky; Winkler

Source: Diabetes, Obesity and Metabolism, Volume 10, Number 12, December 2008 , pp. 1239-1247(9)

Publisher: Blackwell Publishing

Intensive glucose and BP lowering ADVANCEs diabetes care

Source: Inpharma, Volume 1, Number 1656, 2008-09-20 , pp. 15-16(2)

Publisher: Adis International

Reversible Binding of Antidiabetic Drugs, Repaglinide and Gliclazide, with Human Serum Albumin

Authors: Seedher, Neelam; Kanojia, Mamta

Source: Chemical Biology & Drug Design, Volume 72, Number 4, October 2008 , pp. 290-296(7)

Publisher: Blackwell Publishing

Is Ramadan Fasting Safe in Type 2 Diabetic Patients in View of the Lack of Significant Effect of Fasting on Clinical and Biochemical Parameters, Blood Pressure, and Glycemic Control?

Authors: M'guil, M.; Ragala, M. A.; El Guessabi, L.; Fellat, S.; Chraibi, A.; Chebraoui, L.; Israili, Z. H.; Lyoussi, B.

Source: Clinical and Experimental Hypertension, Volume 30, Number 5, July 2008 , pp. 339-357(19)

Publisher: Informa Healthcare

Gliclazide, Inflammation and Atherosclerosis

Author: Drzewoski, Jozef

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 7, Number 3, September 2008 , pp. 224-230(7)

Publisher: Bentham Science Publishers

Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients

Authors: Kigawa, Yoshiaki; Oba, Kenzo; Futami-Suda, Shoko; Norose, Jun; Yasuoka, Hiroko; Suzuki, Kazunari; Ouchi, Motoshi; Watanabe, Kentaro; Suzuki, Tatsuya; Nakano, Hiroshi

Source: Geriatrics and Gerontology International, Volume 8, Number 3, September 2008 , pp. 160-165(6)

Publisher: Blackwell Publishing

Characterization of Mass Ionizable Degradation Products of Gliclazide by LC/ESI-MS

Authors: Bansal, Gulshan; Singh, Manjeet; Jindal, K. C.; Singh, Saranjit

Source: Journal of Liquid Chromatography & Related Technologies, Volume 31, Number 14, January 2008 , pp. 2174-2193(20)

Publisher: Taylor and Francis Ltd